POPPOVÁ, Lucie, Pavlína JANOVSKÁ, Karla PLEVOVÁ, Lenka RADOVÁ, Hana PLEŠINGEROVÁ, Marek BORSKÝ, Jana KOTAŠKOVÁ, Barbara KANTOROVÁ, Michaela HLOŽKOVÁ, Jana FIGULOVÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Alois KOZUBÍK, Šárka POSPÍŠILOVÁ, Šárka PAVLOVÁ a Vítězslav BRYJA. Decreased expression of WNT3, a canonical Wnt pathway ligand is frequent in chronic lymphocytic leukemia progression and identifies patients with short treatment-free survival in mutated IGHV. In Haematologica (2016); 101(s1): 423-424. (21st Congress of the EHA). 2016. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1363948, author = {Poppová, Lucie and Janovská, Pavlína and Plevová, Karla and Radová, Lenka and Plešingerová, Hana and Borský, Marek and Kotašková, Jana and Kantorová, Barbara and Hložková, Michaela and Figulová, Jana and Brychtová, Yvona and Doubek, Michael and Kozubík, Alois and Pospíšilová, Šárka and Pavlová, Šárka and Bryja, Vítězslav}, booktitle = {Haematologica (2016); 101(s1): 423-424. (21st Congress of the EHA)}, title = {Decreased expression of WNT3, a canonical Wnt pathway ligand is frequent in chronic lymphocytic leukemia progression and identifies patients with short treatment-free survival in mutated IGHV}, year = {2016} }
TY - CONF ID - 1363948 AU - Poppová, Lucie - Janovská, Pavlína - Plevová, Karla - Radová, Lenka - Plešingerová, Hana - Borský, Marek - Kotašková, Jana - Kantorová, Barbara - Hložková, Michaela - Figulová, Jana - Brychtová, Yvona - Doubek, Michael - Kozubík, Alois - Pospíšilová, Šárka - Pavlová, Šárka - Bryja, Vítězslav PY - 2016 TI - Decreased expression of WNT3, a canonical Wnt pathway ligand is frequent in chronic lymphocytic leukemia progression and identifies patients with short treatment-free survival in mutated IGHV ER -
POPPOVÁ, Lucie, Pavlína JANOVSKÁ, Karla PLEVOVÁ, Lenka RADOVÁ, Hana PLEŠINGEROVÁ, Marek BORSKÝ, Jana KOTAŠKOVÁ, Barbara KANTOROVÁ, Michaela HLOŽKOVÁ, Jana FIGULOVÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Alois KOZUBÍK, Šárka POSPÍŠILOVÁ, Šárka PAVLOVÁ a Vítězslav BRYJA. Decreased expression of WNT3, a canonical Wnt pathway ligand is frequent in chronic lymphocytic leukemia progression and identifies patients with short treatment-free survival in mutated IGHV. In \textit{Haematologica (2016); 101(s1): 423-424. (21st Congress of the EHA)}. 2016.
|